The effect of recombinant human growth hormone in children with X- linked hypophosphatemia

Pediatrics

Volumn 100, Issue 5, 1997, Pages 879-884

  Seikaly, Mouin G ^a,b,c   Brown, Richard ^b   Baum, Michael ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Growth; Hypophosphatemia; Rickets

Indexed keywords

HUMAN GROWTH HORMONE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GLUCOSE METABOLISM; GROWTH RETARDATION; HUMAN; HYPOPHOSPHATEMIA; LIPID METABOLISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RICKETS; X CHROMOSOME LINKAGE;

CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH; HUMAN GROWTH HORMONE; HUMANS; HYPOPHOSPHATEMIA, FAMILIAL; MALE; PHOSPHATES; RECOMBINANT PROTEINS;

EID: 0030781374     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.100.5.879     Document Type: Article

References (25)

1. Rasmussen H, Tenenhouse HS. Mendelian hypophosphatemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:3717-3745
2. Insogna KL, Broadus AE, Gertner JM. Impaired phosphorus conservation and 1,25 dihydroxyvitamin D generation during phosphorus deprivation in familial hypophosphatemic rickets. J Clin Invest. 1983;71: 1562-1569
3. 3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. J Clin Invest. 1980;66:1020-1032
4. Seikaly MG, Browne RH, Baum M. The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia. Pediatrics. 1994;94:478-481
5. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M. Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med. 1991;325:1843-1848
6. Seikaly MG, Browne RH, Baum M. Nephrocalcinosis is associated with renal tubular acidosis in children with X-linked hypophosphatemia. Pediatrics. 1996;97:91-93
7. Haramati A, Mulroney SE, Lumpkin MD. Regulation of renal phosphate reabsorption during development: implications from a new model of growth hormone deficiency. Pediatr Nephrol. 1990;4:387-391
8. Hirschberg RR, Kopple JD. Increase in renal plasma flow and glomerular filtration rate during growth hormone treatment may be mediated by insulin-like growth factor I. Am J Nephrol. 1988;8:249-253
9. Halloran BP, Spencer EM. Dietary phosphorus and 1,25-dihydroxyvitamin D metabolism: influence of insulin-like growth factor I. Endocrinology. 1988;123:1225-1229
10. Guler HP, Schmid C, Zapf J, Froesch ER. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci U S A. 1989;85:2868-2872
11. Quigley R, Baum M. Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J Clin Invest. 1991;88:368-374
12. Seikaly MG, Baum M. Stimulation of growth hormone secretion in children with X-linked hypophosphatemia. Pediatr Nephrol. 1995;9: 751-752
13. Walker J, Chaussain JL, Bougneres PF. Growth hormone treatment oF children with short stature increases insulin secretion but does not in impair glucose disposal. Clin Endocrinol Metab. 1989;69:253-258
14. Bajaj G, Alexander SR, Browne R, Sakarcan A, Seikaly MG. 125 I-iothalamate clearance in children. A simple method to measure glomerular filtration. Pediatr Nephrol. 1996;10:25-28
15. Patriquin H, Robitaille P. Renal calcium deposition in children: sonographic demonstration of the Anderson-Carr progression. Am J Roentgenol. 1986;146:1253-1256
16. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd ed. Stanford, CA: Stanford University Press; 1959
17. Stark H, Eisenstein B, Tieder M, Rachmel A, Alpert G. Direct measurement of TP/GFR: a simple and reliable parameter of renal phosphate handling. Nephron. 1986;44:125-128
18. Gershberg H, Neumann LL, Man S. Studies on vitamin D-resistant rickets: effects of human growth hormone. Metabolism. 1964;13:636-649
19. Lanes R, Harrison HE. Growth hormone therapy in a poorly growing child with hypophosphatemic rickets. J Endocrinol Invest. 1990;13: 833-837
20. Wilson DM, Lee PDK, Morris AH, et al. Growth hormone therapy in hypophosphatemic rickets. Am J Dis Child. 1991;145:1165-1170
21. Saggese G, Baroncelli GI, Bertelloni S, Perri G. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density. J Pediatr. 1995; 127:395-402
22. Haffner Dieter, Wuhl E, Blum W, Schaefer F, Mehls O. Disproportionate growth following long-term growth hormone treatment in short children with X-linked hypophosphatemia. Eur J Pediatr. 1995; 154:610-613
23. Bishop NJ, dePriester JA, Cole TJ, et al. Reference values for radial bone width and mineral content using single photon absorptiometry in healthy children aged 4 to 10 years. Acta Paediatr. 1992;81:463-468
24. Doi T, Striker LJ, Quaife C, et al. Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-1. Am J Pathol. 1988;131:398-403
25. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int. 1987;31:673-689